ArticleBMJ open2026

Multicentre, double-blind, randomised, placebo-controlled study on the prophylactic use of naldemedine for opioid-induced nausea and vomiting in patients with cancer (POSEIDON study): a protocol paper.

Yo Ishihara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.